Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes-Reference-Cited by-同舟云学术

Progressive Upregulation of PD-1 in Primary and Metastatic Melanomas Associated with Blunted TCR Signaling in Infiltrating T Lymphocytes

Published:2011-06 Issue:6 Volume:131 Page:1300-1307
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Chapon Maxime,Randriamampita Clotilde,Maubec Eve,Badoual Cécile,Fouquet Stéphane,Wang Shu-Fang,Marinho Eduardo,Farhi David,Garcette Marylène,Jacobelli Simon,Rouquette Alexandre,Carlotti Agnès,Girod Angélique,Prévost-Blondel Armelle,Trautmann Alain,Avril Marie-Françoise,Bercovici Nadège

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference25 articles.

1. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired;Ahmadzadeh;Blood,2009

2. New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site;Appay;J Immunol,2006

3. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine;Banchereau;Cancer Res,2001

4. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients;Bercovici;J Immunother,2008

5. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro;Blank;Int J Cancer,2006

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS–STING pathway to mediate GBM immune escape;Journal for ImmunoTherapy of Cancer;2024-04

2. Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy;Frontiers in Immunology;2024-02-14

3. Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review;Journal for ImmunoTherapy of Cancer;2024-01

4. Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor;mBio;2023-10-31

5. Clinical Implications of Immune Checkpoints and the RANK/RANK-L Signaling Pathway in High-Grade Canine Mast Cell Tumors;Animals;2023-06-06